Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1097/BOR.0000000000000316

http://scihub22266oqcxt.onion/10.1097/BOR.0000000000000316
suck pdf from google scholar
C4965315!4965315 !27328333
unlimited free pdf from europmc27328333
    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27328333 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117
pmid27328333
      Curr+Opin+Rheumatol 2016 ; 28 (5 ): 544-9
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Uveitis in children #MMPMID27328333
  • Angeles-Han ST ; Rabinovich CE
  • Curr Opin Rheumatol 2016[Sep]; 28 (5 ): 544-9 PMID27328333 show ga
  • PURPOSE OF REVIEW: The review provides updates on novel risk markers for the development of pediatric inflammatory uveitis and a severe disease course, on treatment of refractory disease, and on the measurement of visual outcomes. RECENT FINDINGS: There are several new genetic markers, biomarkers, and clinical factors that may influence a child's uveitis disease course. It is important to identify children at risk for poor visual outcomes and who are refractory to traditional therapy. Racial disparities have recently been reported. We describe agents of potential benefit. In addition, we discuss the importance of patient reported outcomes in this population. SUMMARY: Uveitis can lead to vision-threatening complications. Timely and aggressive treatment of children identified to be at risk for a severe uveitis course may lead to improved outcomes.
  • |Adolescent [MESH]
  • |Adrenal Cortex Hormones/*therapeutic use [MESH]
  • |Antirheumatic Agents/*therapeutic use [MESH]
  • |Aqueous Humor/chemistry [MESH]
  • |Arthritis, Juvenile/epidemiology [MESH]
  • |Autoimmune Diseases/*drug therapy/epidemiology/genetics/immunology [MESH]
  • |Black or African American [MESH]
  • |Blood Sedimentation [MESH]
  • |Child [MESH]
  • |HLA-B27 Antigen/genetics [MESH]
  • |HLA-DR1 Antigen/genetics [MESH]
  • |HLA-DRB1 Chains/genetics [MESH]
  • |Humans [MESH]
  • |Methotrexate/therapeutic use [MESH]
  • |Recurrence [MESH]
  • |Risk Factors [MESH]
  • |S100 Proteins/immunology [MESH]
  • |Treatment Outcome [MESH]
  • |Tumor Necrosis Factor-alpha/antagonists & inhibitors [MESH]
  • |Uveitis/*drug therapy/epidemiology/genetics/immunology [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box